investorscraft@gmail.com

Intrinsic ValueBastide Le Confort Médical S.A. (0IP1.L)

Previous Close£23.50
Intrinsic Value
Upside potential
Previous Close
£23.50

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Bastide Le Confort Médical SA operates in the medical equipment and services sector, specializing in the sale and rental of health and comfort products for elderly and disabled individuals. The company’s diversified portfolio includes mobility aids, home support equipment, incontinence products, and wellness solutions, distributed through a network of 130 physical stores and an e-commerce platform. Its integrated approach combines product offerings with home support services, positioning it as a key player in France’s aging population market. The company’s focus on accessibility and convenience aligns with growing demand for home healthcare solutions, driven by demographic trends and increasing preference for non-institutional care. While it faces competition from larger medical suppliers and online retailers, its localized store presence and specialized product range provide a competitive edge in serving regional customer needs.

Revenue Profitability And Efficiency

The company reported revenue of €529.8 million for the fiscal year, reflecting its strong market presence in France. However, net income was negative at €-0.9 million, with diluted EPS of €-0.12, indicating profitability challenges. Operating cash flow stood at €66.0 million, suggesting reasonable operational efficiency, though capital expenditures of €-55.4 million highlight ongoing investments in infrastructure and inventory.

Earnings Power And Capital Efficiency

Despite revenue scale, the negative net income points to margin pressures, possibly from competitive pricing or operational costs. The operating cash flow-to-revenue ratio of approximately 12.5% indicates moderate cash generation, but elevated capital expenditures relative to cash reserves (€23.6 million) suggest constrained free cash flow. Debt levels at €408.6 million further weigh on capital efficiency.

Balance Sheet And Financial Health

The company’s financial health is mixed, with €23.6 million in cash against total debt of €408.6 million, indicating high leverage. The absence of dividends aligns with its focus on debt management and reinvestment. The balance sheet reflects the capital-intensive nature of its business model, with significant liabilities tied to inventory and store operations.

Growth Trends And Dividend Policy

Growth is likely tied to demographic trends favoring home healthcare, though recent profitability challenges may slow expansion. The company has not issued dividends, prioritizing liquidity and debt reduction. Future growth may depend on optimizing store performance and expanding digital sales channels to offset margin pressures.

Valuation And Market Expectations

With a market cap of €215.6 million and a beta of 0.879, the stock exhibits moderate volatility relative to the market. The negative earnings and high debt load suggest cautious investor sentiment, though the company’s niche market position could support long-term valuation if profitability improves.

Strategic Advantages And Outlook

Bastide Le Confort Médical’s strategic advantage lies in its specialized product range and localized distribution network. However, operational efficiency and debt management remain critical challenges. The outlook hinges on its ability to capitalize on aging demographics while improving margins through cost controls and e-commerce growth.

Sources

Company description, financial data from disclosed filings, and market metrics from exchange sources.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount